Abstract: Systems and methods for fabricating three-dimensional objects. The system includes an optical imaging system providing a light source; a photosensitive medium adapted to change states upon exposure to a portion of the light source from the optical imaging system; a control system for controlling movement of the optical imaging system, wherein the optical imaging system moves continuously above the photosensitive medium. The method includes moving a maskless optical imaging system providing the light beam in a continuous sequence; presenting the light beam on a portion of the photosensitive medium; lowering a plate upon which the photosensitive medium resides; and applying a new layer of the photosensitive medium.
Type:
Grant
Filed:
May 5, 2009
Date of Patent:
January 28, 2014
Assignees:
Georgia Tech Research Corporation, The Regents of the University of Michigan
Abstract: Mammalian host cells for use in a cell-mediated tranfection process, which contain an RNAi molecule and an expression vector for a pro-apoptotic protein. The method includes inducing apoptotic cell (AC) death in mammalian cells that contain an RNAi molecule capable of downregulating a chosen target gene. Living cells expressing the target gene are then exposed to the ACs. The ACs are processed by the living cells, and the RNAi molecule in the ACs downregulates the expression of the target gene in living cells.
Abstract: The presently disclosed subject matter provides methods of diagnosis of cancer or adverse pregnancy outcomes in a subject by measuring amounts of one or more RNAs present in cancer-derived exosomes isolated from a biological sample from the subject.
Type:
Grant
Filed:
February 24, 2010
Date of Patent:
January 28, 2014
Assignee:
University of Louisville Research Foundation, Inc.
Abstract: The method for synthesizing soft error tolerant combinational circuits includes the step of inputting a combinational circuit to a combinational circuit analyzer for analysis. The analyzer then extracts smaller sub-circuits from said combinational circuit, computes probabilities of input vectors to occur for each of the smaller sub-circuits, produces new multi-level sub-circuits from the extracted sub-circuit, and maximizes logical fault masking against the occurrence of a single fault applied to the new multi-level sub-circuits, the maximizing being based on probabilities of sub-circuit input vectors to occur. Finally, the analyzer merges the new multi-level sub-circuits back to the original inputted combinational circuit.
Type:
Grant
Filed:
December 31, 2012
Date of Patent:
January 28, 2014
Assignee:
King Fahd University of Petroleum and Minerals
Abstract: A method of modulating immune response in an animal is disclosed. Such a method interacting the immature dendritic cells from the animal with an antigen ex vivo so that the immature dendritic cells present the antigen on their surfaces, inducing maturation of the immature dendritic cells ex vivo, and contacting the mature dendritic cells ex vivo with a modulator comprising TRANCE, conservative variants thereof, fragments thereof, analogs or derivatives thereof, or a fusion protein comprising the amino acid sequence of TRANCE, conservative variants thereof, or fragments thereof. After contacting the modulator ex vivo, the mature dendritic cells are introduced into the animal. As a result, immune response in the animal towards the antigen is modulated relative to the immune response against the antigen in an animal in which dendritic cells did not interact with the antigen ex vivo, and did not contact a modulator ex vivo.
Abstract: The invention provides methods for enhancing iodine absorption in a thyroid in a subject and treating thyroid cancer by administering to the subject a composition which includes a multi-kinase inhibitor. Furthermore, the invention provides methods for improving a medical diagnostic procedure based on radioactive iodine in a subject by administering to the subject a composition comprising a multi-kinase inhibitor.
Type:
Grant
Filed:
May 7, 2009
Date of Patent:
January 28, 2014
Assignee:
The Trustees of the University of Pennsylvania
Abstract: The present invention relates to calibration slides for fluorescence detection instruments and processing method of making them. The aim of this invention is to disclose calibration slides with high photostability and long lifetime for fluorescence detection instruments. The calibration slides are fabricated by patterning calibration spot arrays of modified inorganic phosphors on the glass slide. The process for producing a calibration slide comprises the following procedure: 1) Dispersing the inorganic phosphors of rare-earth doped complex in water; 2) Patterning the array of the above suspension on the glass slide. The calibration slides in the present invention employ a very stable fluorescing material that is insensitive to photobleaching, has long lifetime and stability under mild storage condition. The calibration slides in the present invention can be used to calibrate and test for some fluorescence instruments, i.e.
Type:
Grant
Filed:
November 22, 2004
Date of Patent:
January 28, 2014
Assignees:
CapitalBio Corporation, Tsinghua University
Abstract: The present invention provides a process for efficiently producing an alkylated aromatic compound in good yield, by a cross-coupling reaction between an alkyl halide and an aromatic magnesium reagent. A process for producing an aromatic compound represented by Formula (1): R—Ar???(1) wherein R is a hydrocarbon group, and Ar? is an aryl group; the process comprising: reacting a compound represented by Formula (2): R—X??(2) wherein X is a halogen atom, and R is as defined above, with a magnesium reagent represented by Formula (3): Ar?—MgY??(3) wherein Y is a halogen atom, and Ar? is as defined above, in the presence of a catalyst for cross-coupling reactions comprising an iron compound and a bisphosphine compound represented by Formula (4): wherein Q is a divalent group derived from an aromatic ring by removing two hydrogen (H) atoms on adjacent carbon atoms; and each Ar is independently an aryl group.
Abstract: Technologies are generally described for systems and methods for detecting chiral properties of materials and separating materials based on their chiral properties. A chiral vector is constructed from anisotropy properties of a polarization-dependent output signal from a sample. Different types of molecules from the sample can be differentiated based on a magnitude of the chiral vector. Chiral properties of the sample can be detected based on an angle of the chiral vector. The output signal can be a fluorescent emission from the sample and can be used to detect chiral properties of a substantially opaque sample.
Abstract: The present invention relates to devices which operate on gradient optical forces, in particular, nanoscale mechanical devices which are actuable by gradient optical forces. Such a device comprises a waveguide and a dielectric body, with at least a portion of the waveguide separated from the dielectric body at a distance which permits evanescent coupling of an optical mode within the waveguide to the dielectric body. This results in an optical force which acts on the waveguide and which can be exploited in a variety of devices on a nano scale, including all-optical switches, photonic transistors, tuneable couplers, optical attenuators and tuneable phase shifters. The waveguide can also comprise a gap such that two cantilever bridges are formed.
Type:
Grant
Filed:
April 9, 2009
Date of Patent:
January 28, 2014
Assignee:
Yale University
Inventors:
Hongxing Tang, Mo Li, Wolfram Pernice, Chi Xiong
Abstract: An exemplary embodiment of the present invention includes a method for increasing temporal resolution in Phase Contrast (PC) MR imaging. The increased temporal resolution may be obtained by reusing information encoded into phase of an MRI signal where said reuse occurs prior to the difference reconstruction.
Type:
Grant
Filed:
February 1, 2010
Date of Patent:
January 28, 2014
Assignee:
The Ohio State University
Inventors:
Orlando P. Simonetti, Yiu-Cho Chung, Hung-Yu Lin, Yu Ding, Jacob A. Bender
Abstract: The invention relates to a recombinant factor VIII that includes one or more mutations at an interface of A1 and C2 domains of recombinant factor VIII. The one or more mutations include substitution of one or more amino acid residues with either a cysteine or an amino acid residue having a higher hydrophobicity. This results in enhanced stability of factor VIII. Methods for making the recombinant factor VIII, pharmaceutical compositions containing the recombinant factor VIII, and use of the recombinant factor VIII for treating hemophilia A are also disclosed.
Abstract: Synthetic cholesterylamine-linkers can include derivatives of cholesterol, cholesteryl, or sitosteryl coupled through the linker to an agent for delivery into cells. The cholesterylamines are thought to mimic cholesterol in the capacity and mechanism for enhanced entry into cells. The configuration of the cholesterylamine-linker that is thought to provide for enhanced entry into cells includes a cholesterylamine that is coupled to a linker from the amine, and which linker includes a negative charge at a spatial distance from the amine of the cholesterylamine.
Abstract: The present invention relates to novel thiazolidinedione derivatives expressed by the following formula (I) and the uses thereof. More specifically, the present invention relates to novel thiazolidinedione derivatives expressed by the following formula (I) and a pharmaceutical composition comprising the same. The novel thiazolidinedione derivatives of formula (I) according to the present invention can be effectively used for the prevention or treatment of cardiovascular disease, gastrointestinal disease and renal disease by inhibiting the activity of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) that decomposes prostaglandins as well as useful for the prevention of hair loss and the stimulation of hair growth, and osteogenic stimulation and wound healing.
Type:
Grant
Filed:
December 30, 2009
Date of Patent:
January 28, 2014
Assignee:
Industry-Academic Cooperation Foundation, Chosun University
Abstract: A polymer-carbon sorbent for removing carbon dioxide, heavy metals and toxic materials from a flue gas from a combustion process, such as coal-fired power plants, is described. The sorbent comprises a carbonaceous sorbent material and a cured amine-containing polymer, and sulfur. The polymer-carbon sorbents are formed by curing a curable amine-containing polymer in the presence of the carbonaceous sorbent material, sulfur, a cure accelerator and, optionally, a cure activator. A convenient carbonaceous sorbent material is an activated carbon, and a convenient curable amine-containing polymer is an allyl-containing poly(ethyleneimine), having a number average molecular weight between about 1,000 and about 10,000. The polymer-carbon sorbents may contain sulfur in excess of an amount needed to cure the curable amine-containing polymer. Such polymer-carbon sorbents are shown to capture more mercury, in both elemental an ionic forms, compared to activated carbon and adsorb carbon dioxide.
Abstract: A non-planar, ultra-wide band, quasi-self-complementary feed antenna is disclosed. The antenna provides an invariant phase center location over its entire frequency band, is compact and includes a low profile, and includes input matching better than is currently available over a decade of frequency bandwidth. The very compact feed couples dual polarization electromagnetic energy to a transmitter from free space or air with minimum losses and mismatches over a very wide frequency band.
Abstract: A method for identifying peptides using tandem mass spectrometry takes the spectrum for a peptide to be analyzed and uses a scoring function to score a match between the spectrum and each candidate peptide in a peptide database. The scoring function has a value corresponding to a number of fragment peaks in the spectrum that match fragment peaks in a spectrum of the candidate peptide. Using the match scores, a generating function of the spectrum is computed to determine the number of peptide reconstructions at each value of the scoring function. The generating function is then used to determine the number of candidate peptides for each match score and the probability of a peptide having a given match score to the spectrum. A spectral probability can be determined by calculating the total probability of all peptides with scores equal to or larger than the given match score.
Type:
Grant
Filed:
June 2, 2008
Date of Patent:
January 28, 2014
Assignee:
The Regents of the University of California
Inventors:
Sangtae Kim, Nitin Gupta, Pavel A. Pevzner
Abstract: The present technology provides methods and compositions for the treatment of tissue-damage related immune dysregulation by administering a composition comprising one or more of CD24; CD24 fragments, variants and derivatives, CD24Fc fusion proteins; HMBG1-binding proteins, binding proteins to HMBG1 Box B; antagonists of HMGB1, polyclonal, monoclonal, recombinant, chimeric, humanized scFv antibodies and antibody fragments to HMGB1 or fragments of HMGB1 and antibodies that bind and suppress the activity of HMGB1 Box B; Siglec 10 agonists such as anti-Siglec 10 antibodies; and combinations thereof to a patient.
Type:
Grant
Filed:
March 21, 2012
Date of Patent:
January 28, 2014
Assignee:
The Regents of The University of Michigan
Inventors:
Yang Liu, Pan Zheng, Guo-Yun Chen, Xincheng Zheng, Xi Cheng, Steve Kunkel
Abstract: Elevated levels of cathepsin E (catE) are demonstrated to be diagnostic of intestinal forms of cancer, such as colorectal cancer. Elevated levels of cathepsin E (catE, monomeric forms) are demonstrated to be detectable in the urine of animals having colorectal cancer, and a diagnostic/screening method for identifying and/or detecting colorectal cancer in an animal from a urine sample is provided. Specific tissue immunohistochemcial staining for catE (monomeric forms) in dysplastic tissue is also disclosed, and is shown to correlate with the level of dysplastic lesion severity. Hence, a method for identifying and determining the level of dysplastic lesion severity is provided. Cathepsin E mRNA transcription and expression levels are also demonstrated to be upregulated in dysplastic tissue, relative to non-dysplastic tissue. Hence, a method for transcriptionally profiling an animal to monitor the progression of colorectal disease is provided.
Type:
Grant
Filed:
December 28, 2010
Date of Patent:
January 28, 2014
Assignee:
University of Notre Dame
Inventors:
Rudolph M. Navari, Mary Prorok, Francis J. Castellino
Abstract: The present invention provides a method for obtaining a plant with increased stress resistance relative to a wild-type plant, comprising: (a) introducing at least one mutation or exogenous nucleic acid into the genome of one or more plant cells which results in reduced activity associated with SAL1 or a homologue thereof in said one or more plant cells; (b) regenerating one or more plants from said one or more plant cells; and (c) selecting one or more plants that have increased stress resistance relative to a wild-type plant.
Type:
Grant
Filed:
June 19, 2008
Date of Patent:
January 28, 2014
Assignee:
The Australian National University
Inventors:
Barry James Pogson, Philippa Bronwyn Wilson, Jan Bart Rossel